TrianglePUBLICATIONS · 28715249
Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2017 Sep 10
- First author
- Turtle CJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Turtle CJ
- type
- Author
- name
- Hay KA
- type
- Author
- name
- Hanafi LA
- type
- Author
- name
- Li D
- type
- Author
- name
- Cherian S
- type
- Author
- name
- Chen X
- type
- Author
- name
- Wood B
- type
- Author
- name
- Lozanski A
- type
- Author
- name
- Byrd JC
- type
- Author
- name
- Heimfeld S
- type
- Author
- name
- Riddell SR
- type
- Author
- name
- Maloney DG
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Turtle CJ
- type
- Author
- name
- Hay KA
- type
- Author
- name
- Hanafi LA
- type
- Author
- name
- Li D
- type
- Author
- name
- Cherian S
- type
- Author
- name
- Chen X
- type
- Author
- name
- Wood B
- type
- Author
- name
- Lozanski A
- type
- Author
- name
- Byrd JC
- type
- Author
- name
- Heimfeld S
- type
- Author
- name
- Riddell SR
- type
- Author
- name
- Maloney DG
- type
- Author
- bibliography ids
- nci-bib-61ef973f1de51900f4e66c27
- book metadata
- content sha256
- fca918bfb467d02453684bbfa768f76f72c95564c9e06a4b607d5dcd2ca51660
- document type
- citation
- dois
- 10.1200/JCO.2017.72.8519
- electronic publication date
- display
- 2017 Jul 17
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28715249
- immutable id
- pubmed:28715249@fca918bfb467d02453684bbfa768f76f72c95564c9e06a4b607d5dcd2ca51660
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 26
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3010-3020
- volume
- 35
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 28715249
- provenance
- batch id
- 1c173f0e18be0c6d461b
- provider
- NCBI PubMed ESummary
- record sha256
- 7d5f50992a3b63f7ce5dfa1460262ebe26b4fdac41b370592e05a2c72f96cb6c
- response sha256
- 27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
- retrieved at
- 2026-09-09T23:47:25.975513+00:00
- publication date
- display
- 2017 Sep 10
- precision
- day
- year
- 2017
- publication types
- Clinical Trial, Phase I
- Clinical Trial, Phase II
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor-Modified T Cells After Failure of Ibrutinib.
Preserved source evidence · Not medical advice